Shouxiangu Pharma’s Flat Trend Signals Urgent Need for R&D and Investor‑Relations Revamp
Discover why Zhejiang Shouxiangu Pharmaceutical’s shares stagnate, the risks of complacency, and how a strategic reboot could unlock hidden value.
2 minutes to read



